Since the discovery of the endocannabinoid system, evidence has been progressively accumulating to suggest that 2-arachidonoylglycerol (2-AG) rather than anandamide (AEA) is the endogenous ligand for both cannabinoid (CB) receptors. Moreover, other studies have shown that another lipid molecule, 2-arachidonyl-glycerol ether (2-AGE, noladin ether), which acts as a full agonist at cannabinoid receptors, might occur in tissues. Having previously designed a resorcinol-AEA hybrid model, in this paper we have explored the cannabinoid receptor binding properties, the CB1 functional activity, and the

ABSTRACT The identification of the cannabinoid receptor type 1 (CB1 receptor) was the milestone discovery in the elucidation of the behavioural and emotional responses induced by the Cannabis sativa constituent Δ 9 ‐tetrahydrocannabinol. The subsequent years have established the existence of the endocannabinoid system. The early view relating this system to emotional responses is reflected by the fact that N‐ arachidonoyl ethanolamine, the pioneer endocannabinoid, was named anandamide after the Sanskrit word ‘ ananda ’, meaning ‘bliss’. However, the emotional responses to cannabinoids are not

The primary psychoactive ingredient in cannabis, Δ 9 -tetrahydrocannabinol (Δ 9 -THC), affects the brain mainly by activating a specific receptor (CB1). CB1 is expressed at high levels in many brain regions, and several endogenous brain lipids have been identified as CB1 ligands. In contrast to classical neurotransmitters, endogenous cannabinoids can function as retrograde synaptic messengers: They are released from postsynaptic neurons and travel backward across synapses, activating CB1 on presynaptic axons and suppressing neurotransmitter release. Cannabinoids may affect memory, cognition, a

Cannabinoid A cannabinoid is a chemical found in the cannabis (marijuana) plant. There are 113 cannabinoids that scientists know of, but there are likely more. Two of the best known cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is a psychoactive drug, meaning it can make you feel and think differently.[1] Not all cannabinoids are psychoactive and each one works differently. All cannabinoids share a similar chemical structure and are researched for treating diseases.[2] Receptors in the body Cannabinoids work by connecting, or binding, to receptors in the body. These receptors make up a system called the endocannabinoid system (ECS). There are two types of receptors: CB1 (cannabinoid receptor type 1) and CB2 (cannabinoid receptor type 2). CB1 receptors are mostly found in the central nervous system, which is made up of the brain and spine. It is also found in other places in the body like sex organs. CB2 is found in the peripheral nervous system in other parts of the body.

The cannabinoid receptors are a class of receptors within the G-protein coupled receptor superfamily. Their ligands are known as cannabinoids or endocannabinoids depending on whether they come from external or internal (endogenous) sources, respectively (Howlett et al. 2002). Endocannabinoids serve as intercellular lipid messengers, signaling molecules that are released from one cell and activate the cannabinoid receptors present on other cells. Cannabinoid type 1 (CB1) receptors (Gerrard et al. 1990) are thought to be the most widely expressed G-protein coupled receptors in the brain, lungs,

The endocannabinoid system (ECS) is one of the most crucial systems in the human organism, exhibiting multi-purpose regulatory character. It is engaged in a vast array of physiological processes, including nociception, mood regulation, cognitive functions, neurogenesis and neuroprotection, appetite, lipid metabolism, as well as cell growth and proliferation. Thus, ECS proteins, including cannabinoid receptors and their endogenous ligands' synthesizing and degrading enzymes, are promising therapeutic targets. Their modulation has been employed in or extensively studied as a treatment of multipl

Medical cannabis is the dried flowers of the female Cannabis sativa L. plant. Cannabis contains a number of active elements, including dronabinol (THC) and cannabidiol (CBD). Dronabinol is usually the main ingredient. The body’s own cannabinoid system has been identified. The discovery of this system, which comprises endocannabinoids and receptors, confirmed that cannabis has a positive effect on certain illnesses and conditions. Two types of cannabinoid receptors have been identified: CB1 and CB2 receptors. The first type CB1 is mostly found in the central nervous system, modulate pain. It al

neurotransmitter anandamide (also found in chocolate) at the CB1 receptors in the brain. Other cannabinoids include Cannabidiol (CBD), cannabinol (CBN) and tetrahydrocannabivarin